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Background: The innate immune response is the first line of defence against invading microorganisms and it is also
activated in different neurologic/neurodegenerative pathological scenarios. As a result, the family of the innate
immune toll-like receptors (TLRs) and, in particular, the genetic/pharmacological manipulation of the TLR-4 signalling
pathway emerges as a potential therapeutic strategy. Growing evidence relates stress exposure with altered immune
responses, but the precise role of TLR-4 remains partly unknown.
Methods: The present study aimed to elucidate whether the elements of the TLR-4 signalling pathway are activated after
acute stress exposure in rat brain frontal cortex and its role in the regulation of the stress-induced neuroinflammatory
response, by means of its pharmacological modulation with the intravenous administration of the TLR-4 specific
inhibitor TAK-242. Considering that TLR-4 responds predominantly to lipopolysaccharide from gram-negative
bacteria, we checked whether increased intestinal permeability and a resultant bacterial translocation is a potential
regulatory mechanism of stress-induced TLR-4 activation.
Results: Acute restraint stress exposure upregulates TLR-4 expression both at the mRNA and protein level. Stress-induced
TLR-4 upregulation is prevented by the protocol of antibiotic intestinal decontamination made to reduce indigenous
gastrointestinal microflora, suggesting a role for bacterial translocation on TLR-4 signalling pathway activation. TAK-242
pre-stress administration prevents the accumulation of potentially deleterious inflammatory and oxidative/nitrosative
mediators in the brain frontal cortex of rats.
Conclusions: The use of TAK-242 or other TLR-4 signalling pathway inhibitory compounds could be considered
as a potential therapeutic adjuvant strategy to constrain the inflammatory process taking place after stress
exposure and in stress-related neuropsychiatric diseases.
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The innate immune response is the first line of host
defence against invading microorganisms [1]. It is also
specifically activated both at the peripheral and central
nervous system (CNS) level in different neurologic/
neurodegenerative pathological scenarios (that is,
stroke, multiple sclerosis and Alzheimer’s disease) [2]. The* Correspondence: bgbueno@med.ucm.es
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reproduction in any medium, provided the oractivation of the innate immune system in these CNS dis-
orders presents an apparent “doubled edged sword” poten-
tial, exerting either beneficial or detrimental effects that
clearly warranted further investigation to manage its
proper pharmacological modulation for therapeutic pur-
poses [3].
The main agents of the innate immune response are
the family of toll-like receptors (TLRs). TLRs are pattern
recognition receptors that detect circulating pathogen-
associated molecular patterns (PAMPs), which are found
in pathogens but not in mammalian cells. These pat-
terns, such as the bacterial lipopolysaccharide (LPS),Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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by the production of cytokines, enzymes and other in-
flammatory mediators, and the activation of oxidative
and nitrosative stress pathways that can have an im-
pact on several aspects of the CNS homeostasis and
pathology [4,5].
TLRs are highly expressed in immune cells in response
to pathogens, a variety of cytokines and environmental
stressors [6]. In the last years, TLR expression has been
found in different CNS intrinsic cell types, such as neu-
rons, astrocytes, resident microglia, or cells in cerebral
microvasculature, plexus choroideus and leptomeninges
[7]. This ubiquitous expression of the TLR family has
challenged the role of the immune innate system in the
brain and, as a result, the view of the brain as an immune
privileged organ has been re-evaluated. In addition, this
extended distribution could suggest other roles for TLRs
in non-infectious CNS diseases/injury, recognizing a num-
ber of endogenous molecules released from damaged tis-
sues (damage-associated molecular patterns, or DAMPs)
[8] in a great diversity of processes, such as autoimmunity,
neurogenesis, brain plasticity and behaviour [7,9,10].
The most studied member of the TLR family is TLR-4,
which predominantly responds to LPS from Gram-negative
bacteria [11] through its co-receptor, myeloid differenti-
ation protein-2 (MD-2), a requisite for LPS signalling of
TLR-4 [12]. To achieve specificity of signalling, TLR-4 re-
cruits some other adapter proteins during intracellular sig-
nal transduction, such as the myeloid differentiation factor
88 (MyD88). After various consecutive steps in the trans-
duction pathway (that is, specific kinases), the activation of
the prototypic inflammatory nuclear transcription factor
NF-κB [13] culminates in the production of NF-κB-
dependent pro-inflammatory mediators such as, for ex-
ample, the enzymes inducible nitric oxide synthase (iNOS)
and inducible cyclooxygenase (COX-2) [14].
In the last years, increasing attention has been paid to
the potential role of the immune system in the patho-
physiology of stress-related neuropsychiatric diseases such
as major depression or chronic fatigue syndrome [15,16].
In many cases, both depression and chronic stressors have
been associated with decreased acquired immunity and an
increased susceptibility to infections and inflammation,
with important general consequences for health [17].
However, in the last decade it has been demonstrated that
after stress exposure or during certain episodes of depres-
sion an inflammatory/immune innate response is strongly
activated [15]. Thus, inflammatory cellular pathways are
activated in particular brain areas (that is, the frontal cor-
tex (FC)) after stress exposure, with a key role for NF-κB
as a crucial factor in the oxidative/nitrosative damage pro-
duced [18]. On the other hand, NF-κB activation has also
been related to neuronal plasticity and survival, depending
on the activated cell type [19].The precise role of TLR-4 in the inflammatory re-
sponses activated after stress exposure in the brain and
periphery are still a matter of debate, as well as the regula-
tory mechanism(s) implicated. Remarkably, some models
of stress show increased intestinal permeability and a re-
sultant bacterial translocation to the systemic circulation
and/or other organs such as the liver, spleen and mesen-
teric lymph nodes [20]. These circulating Gram-negative
bacteria are a major source of LPS, which can activate
brain TLR-4 through multiple pathways, inducing a
neuroinflammatory response. This proposed mechan-
ism known as “leaky gut” also takes place in patients
with depression or chronic fatigue syndrome and it has
been related to the inflammatory pathophysiology of
the diseases [16,21]. However, the molecular pathways
affected may vary between pathologies: in depression,
there are significant associations between bacterial
translocation and increased oxidative/nitrosative stress
pathways [16], while in chronic fatigue syndrome bac-
terial translocation is accompanied by increased levels
of cytokines [21].
In a stress-related scenario, TLR-4 has been presented
as a specific regulator of the adrenal response to inflam-
matory stimuli [22], acute and chronic stress exposure
included [23,24].
Taking into account all this background, the present
study aimed to evaluate whether the TLR-4 signalling
pathway is activated after acute stress exposure in rat FC
and the potential regulatory mechanisms implicated
(that is, bacterial translocation).
Moreover, the possible role of TLR-4 in the regulation
of stress-induced neuroinflammation was also analyzed




Male outbred Wistar Hannover rats (HsdRccHan:Wist,
from Harlan, Spain), initially weighing 200 to 225 g, were
housed five per cage and maintained in an animal holding
room controlled at a constant temperature of 24 ± 2°C
with a relative humidity of 70 ± 5% and a 12 hour light–
dark cycle (lights on at 08:00). Animals were fed a stand-
ard pellet chow (standard rat chow A04 SAFE, Scientific
Animal Food and Engineering, Augy, France) with free ac-
cess to fresh tap water and were maintained under con-
stant conditions for 7 days prior to stress. All
experimental protocols followed the guidelines of the Ani-
mal Welfare Committee of the Universidad Complutense
according to European legislation (2003//65/ EC).
Experimental design
First, in order to include a positive control to directly
test the connection between infection and upregulation
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traperitoneally (i.p.) with 500 μg/kg LPS and sacrificed 2
hours later. A correspondent control group was included
(Control).
Second, in order to verify the time course of TLR-4 ac-
tivation after stress exposure, three different groups of
animals (n = 6 per group) were respectively exposed to 2
hours (S2h), 6 hours (S6h) and 4 days (6 hours/day for 4
days) (S4d) of restraint stress. A correspondent control
group was included (Control).
Next, in order to explore the possibility of Gram-
negative LPS induction of TLR-4 caused by intestinal
bacterial translocation after stress, stressed animals were
treated with antibiotic (STRESS + ATB) or its vehicle
(STRESS).
In order to clarify the direct implication of the TLR-4
pathway in the stress-induced neuroinflammation, two
groups of animals were intravenously (i.v.) injected with
the TLR-4 inhibitor TAK-242 (S(TAK)) or vehicle
(STRESS) and then submitted to 6 hours of restraint
stress.
None of the parameters studied were modified in the
two different vehicle-treated groups of rats when com-
pared with the non-injected animals. To simplify figures,
both groups were unified into one (STRESS).
Pharmacological tools
TAK-242 (ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl)sul
famoyl]cyclohex-1-ene-1-carboxylate) [25] is a specific
inhibitor of TLR-4 that works by blocking its intracellu-
lar domain TIR Toll/IL-1 Receptor [26] without affecting
the extracellular docking with its main ligand LPS [27].
Thus, TAK-242 inhibits the intracellular signalling of TLR-
4, preventing the binding to its adapter molecules [28].
TAK-242 was i.v. injected in the tail vein at a dose of
0.5 mg/kg immediately after (approximately 10 seconds)
introducing the animal to the plastic restrainer. This
dose was chosen on the basis of previous in vivo studies
reporting its anti-inflammatory/antioxidant and neuro-
protective profile in microglia exposed to hypoxia [29].
Dimethyl sulphoxide at a concentration of 0.9% was
used as vehicle.
Intestinal antibiotic decontamination
We followed a previously described protocol for rats
[30]. Briefly, animals were given drinking water ad libi-
tum containing streptomycin sulphate (2 mg/ml) and
penicillin G (1,500 U/ml), 5 days before the first session
of stress (at 08:00) until the moment of sacrifice, to re-
duce indigenous gastrointestinal microflora. The amount
of antibiotic consumed was >75% of that initially admin-
istrated. To discard a possible effect of the antibiotic
treatment on the immune/inflammatory response, the
levels of NF-κB, iNOS and COX-2 in control and LPS(0.5 mg/kg i.p.) rats with and without antibiotic were
checked and no major changes were found between the
different groups (data not shown).
Stress protocol and tissue samples
The restraint stress protocol was performed using a
plastic rodent restrainer that allowed for a close fit to
rats starting in all groups at 09:00 [31]. Control animals
were not subjected to stress, but were handled at 09:00
for a few seconds, and food and water were removed
during the period of time that the stressed rats were
kept in the restrainer.
Animals were killed immediately after restraint using so-
dium pentobarbital (320 mg/kg, i.p.; Vetoquinol, Madrid,
Spain). The lethal injection of sodium pentobarbital was
performed when the animal was still in the plastic re-
strainer at the end of the stress period. After decapitation,
the brain was removed from the skull, and after careful re-
moval of the meninges and blood vessels, the frontal cor-
tical areas from both brain hemispheres were excised and
frozen at -80ºC until assayed. Peripheral leukocytes ex-
press TLR-4 and could be a significant source of pro-
inflammatory mediators after stress exposure. To manage
this possible confounding factor, a group of stressed ani-
mals was transcardially saline-perfused prior to collection
of brain tissue. This group of animals did not present dif-
ferences in TLR-4, iNOS and COX-2 expression in brain
homogenate samples compared to the group of stressed
animals without prior saline perfusion.
Rat brain FC was chosen because of its high levels of
pro-inflammatory/anti-inflammatory mediators, its suscep-
tibility to the neuroinflammatory process elicited by stress
[17] and finally because this brain area is an important
neural substrate for the regulation of the hypothalamo-
pituitary-adrenal axis response to stress [32].
Preparation of nuclear extracts
A modified procedure based on the method of Schreiber
and colleagues [33] was used: tissues (brain FC) were ho-
mogenized in 300 μl buffer (10 mmol/lN-2-hydroxyethyl
piperazine-N-2-ethanesulfonic acid (pH 7.9); 1 mmol/l
EDTA, 1 mmol/l EGTA, 10 mmol/l KCl, 1 mmol/l di-
thiothreitol, 0.5 mmol/l phenylmethylsulfonyl fluoride,
0.1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml Na-
p-tosyll-lysine-chloromethyl ketone, 5 mmol/l NaF,
1 mmol/l NaVO4, 0.5 mol/L sucrose, and 10 mmol/l
Na2MoO4). After 15 minutes, Nonidet P-40 (Roche,
Mannheim, Germany) was added to reach a 0.5% con-
centration. The tubes were gently vortexed for 15 sec-
onds, and nuclei were collected by centrifugation at
8000 g for 5 minutes. Supernatants were considered as
the cytosolic fraction. The pellets were resuspended in
100 μl buffer supplemented with 20% glycerol and
0.4 mol/l KCl and gently shaken for 30 minutes at 4ºC.
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tion at 13,000 g for 5 minutes, and aliquots of the
supernatant were stored at -80ºC. All steps of the frac-
tionation were carried out at 4ºC.
Bacterial translocation
The abdominal skin was shaved and sterilized with an
iodine solution. After blood sampling, mesenteric lymph
nodes (MLNs) were removed under sterile conditions.
After weighing and homogenization, aliquots (2 ml) of
serial 10-fold dilutions of the suspension were plated
onto 5% blood and McConkey’s agar plates for recovery
of aerobic bacteria, and Brucella blood agar plates sup-
plemented with vitamin K1 and hemin for anaerobic
bacteria. After 24 and 48 hours incubation at 37°C for
aerobic and anaerobic cultures, respectively, colonies
were counted [18]. Quantitative culture results were
expressed as the number of colony-forming units (CFU)
per mg tissue. Any positive MLN cultures were consid-
ered indicative of bacterial translocation from the intes-
tinal lumen. Bacterial strain was identified by Gram
stain, biochemical tests and standard biochemical identi-
fication systems.
In addition, a piece of tissue from the left hepatic lobule
was obtained and immediately frozen for the posterior de-
termination of the lipopolysaccharide binding protein
(LBP) mRNA levels. LBP is a soluble acute-phase protein
that binds to LPS to elicit immune responses by present-
ing the LPS to TLR-4. The hepatic tissue was used for this
determination because it is one of the main organs where
LBP protein synthesis is increased in acute phase re-
sponses against LPS [34].
Western blot analysis
Brain frontal cortices were used to determine expression
levels of the oxidative/nitrosative and inflammatory en-
zymes iNOS and COX-2, the inflammatory transcription
factor NF-κB (p65 subunit), and TLR-4 and its adapter
proteins MyD88 and MD-2. In the case of the NF-κB sub-
unit p65, the analysis was carried out in nuclear extracts
from FC samples; for the inhibitory protein of NF-κB,
IκBα, cytosolic extracts were used (see previous point).
After adjusting protein levels in the resultant superna-
tants, homogenates were mixed with Laemmli sample
buffer (BioRad, Hercules, CA, USA) and 10 μl (1 mg/ml)
were loaded into an electrophoresis gel. Next, the mem-
branes were blocked in 10 mM Tris-buffered saline con-
taining 0.1% Tween-20 and 5% skim milk/BSA, then the
membranes were incubated with specific primary anti-
bodies: from Santa Cruz Biotechnology (CA, USA) against
iNOS (rabbit polyclonal antibody raised against a peptide
mapping at the amino terminus of iNOS of human origin
in a dilution of 1:1000 in TBS-Tween) (sc-651); COX-2
(goat polyclonal antibody raised against a peptide mappingat the C-terminus of COX-2 of mouse origin in a dilution
of 1:750 in 5% BSA in TBS-Tween) (sc-1747); NF-κB p65
subunit (rabbit polyclonal NF-κB p65 raised against an
epitope mapping within the N-terminus of NF-κB p65 of
human origin in a dilution of 1:500 in BSA 2%) (sc-109);
TLR-4 (goat polyclonal antibody raised against an epitope
mapping within an extracellular domain of TLR4 of mouse
origin in a dilution of 1:1000 in BSA 2%) (sc-16240); MD-2
(rabbit polyclonal antibody raised against an epitope corre-
sponding to amino acids 1–160 representing full length
MD-2 of human origin in a dilution of 1:1000 in BSA 2%)
(sc-20668); from Abcam (Cambridge, UK) against MyD88
(rabbit polyclonal antibody raised against amino acids
279–296 of MyD88 of human origin in a dilution of 1:1000
in BSA 2%) (ab-2064); and from R&D systems (Abingdon,
UK) against 4-hydroxynonenal (4-HNE) adducts of his-
tidine residues (monoclonal raised against HLH-coupled
4-HNE in a dilution of 1:1000 in BSA 5%) (MAB3249).
After washing with 10 mM Tris-buffered saline containing
0.1% Tween-20, the membranes were incubated with the
respective horseradish peroxidase-conjugated secondary
antibodies for 90 minutes at room temperature. Blots were
imaged using an Odyssey® Fc System (Li-COR Biosciences,
Lincoln, Nebraska USA) and were quantified by densitom-
etry (NIH ImageJ® software, National Institutes of Health,
Bethesda, Maryland, USA). Densitometric data are
expressed in arbitrary units of optical density. In all West-
ern blot analyses, the housekeeping gene β-actin was used
as loading control except for the case of the NF-κB p65
subunit in which the loading control was the nuclear fac-
tor SP1 (blots shown in the respective figures).
Real time-PCR analysis
Total cytoplasmic RNA was prepared from samples of
FC using TRIZOL® reagent (Invitrogen, Life Technolo-
gies, Carlsbag, CA, USA) (following the TRIZOL® data-
sheet); aliquots were converted to cDNA using random
hexamer primers. Semi-quantitative changes in mRNA
levels were estimated by real time-PCR (RT-PCR).
Semi-quantitative changes in mRNA levels were esti-
mated by using the following cycling conditions: 35 cy-
cles of denaturation at 95ºC for 10 seconds, annealing at
58 to 61ºC for 15 seconds depending on the specific set
of primers, and extension at 72ºC for 20 seconds. Reac-
tions were carried out in the presence of SYBR green
(1:10000 dilution of stock solution from Molecular
Probes, Eugene, OR, USA), carried out in a 20-l reaction
in a Rotor-Gene (Corbett Research, Mortlake, NSW,
Australia). The primers used were for TLR-4: forward:
5′-AAC CAG CTG TAT TCC CTC AGC ACT-3′ and
reverse: 5′-ACT GCT TCT GTT CCT TGA CCC ACT-3′;
for MD-2: forward: 5′-CTC CGA TGC AAT TAT TTC
CTA C −3′ and reverse: 5′-TGG CAC AGA ACT TCC
TTA CG-3′; for MyD88: forward: 5′-TAA GTT GTG TGT
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TTC TGT TGG ACA CCT-3′; for iNOS: forward: 5′-CTG
CTG GTG GTG ACA AGC ACA TTT-3′ and reverse:
5′-ATG TCA TGA GCA AAG GCG CAG AAC-3′; for
COX-2: forward: 5′-ACT GGG CCA TGG AGT GGA
CTT AAA-3′ and reverse: 5′-AAC TGC AGG TTC
TCA GGG ATG TGA-3′; for IL-1β: forward: 5′- ACC
TGC TAG TGT GTG ATG TTC CCA-3′ and reverse
5′- AGG TGG AGA GCT TTC AGC TCA CAT-3′;
and finally for LBP: forward: 5′- TGA CAT GTT ACC
GCC TGA CTC CAA −3′, reverse: 5′- AGA CCA
CTG TTC CAA GAA GCT CCA −3′. Relative mRNA
concentrations were calculated from the take-off point
of reactions using included software, and tubulin pri-
mer levels were used to normalize data.
Perfusion and histology
At the end of the last session of stress, rats were anaes-
thetized and perfused via the ascending aorta with 4%
paraformaldehyde in 0.1 M PBS buffer, pH 7.4, and the
brains were removed, overnight postfixed, and cryo-
protected in 15% sucrose for 24 hours. Regularly
spaced series of 30-μm thick coronal sections were col-
lected in cryoprotectant solution and stored at −20°C
until processing.
Immunohistochemistry
To identify the cell type(s) displaying TLR-4-like immuno-
reactivity, a dual immunofluorescence protocol was used.
Sections were incubated with antisera for TLR-4 (antibody
already described in Western Blot analysis section
(1:500) and either/or (a) a rabbit polyclonal Anti-
NeuN Alexa Fluor® 488 Conjugate (Millipore Ibérica,
Madrid, Spain; ABN78A4, 1:3000), used here as marker
for neurons; (b) a rabbit polyclonal anti-ionized cal-
cium binding adaptor molecule 1 (IBA1) (WAKO Pure
Chemical Industries Ltd. #019-19741, 1:3000), used
here as a marker for parenchymal microglia; (c) a
mouse monoclonal anti-glial fibrillary acidic protein
(GFAP)-like astrocyte marker (610566, BD Transduc-
tion Laboratories, San Jose, CA, USA).
The respective primary antisera were incubated for
48 hours at 4°C. Subsequently, the sections were incu-
bated for 1 to 2 hours at room temperature with Alexa
555-conjugated donkey anti-goat IgG (1:1000; Molecu-
lar Probes/Invitrogen) to localize TLR-4 and with Alexa
488-conjugated donkey anti-rabbit IgG (1:2000; Molecular
Probes/Invitrogen) for NeuN, IBA1 and GFAP, respect-
ively. Samples were mounted using Prolong Gold antifade
reagent with DAPI (Life Technologies). Control experi-
ments included incubation of tissue sections from control
and stressed animals with each antiserum singly and then
with both secondary antisera to ensure that the latter did
not cross-react with the inappropriate primary antiserumor with each other. Imaging was performed using a Leica
SP2 TCS AOBS spectral confocal microscope (Wetzlar,
Germany).NF-κB transcription factor assay
NF-κB transcription factor activity was determined on
nuclear extracts using an ELISA-based kit, which al-
lows detecting and quantifying the specific transcrip-
tional activity of NF-κB (Cayman Chemicals, Tallin,
Estonia).
Briefly, nuclear extracts were incubated in a multiwell
plate coated with specific NF-κB p65 subunit response
element probes, and p65 bounded to its response elem-
ent probe was detected using a specific antibody against
this subunit. Horseradish peroxidase-labelled secondary
antibody was added and the binding was detected by
spectrophotometry. Measurement was performed ac-
cording to the manufacturer’s instructions. This assay is
specific for p65 activation, and it does not cross-react
with other NF-κB subunits, such as p50.Lipid peroxidation
Lipid peroxidation was measured by the thiobarbituric
acid test [35] with some modifications. Cerebral cortex
was sonicated in 10 volumes 50 mmol/l phosphate buffer
and deproteinized with 40% trichloroacetic acid and
5 mol/l HCl, followed by the addition of 2% (wt/vol) thio-
barbituric acid in 0.5 mol/l NaOH. The reaction mixture
was heated in a water bath at 90°C for 15 minutes and
centrifuged at 12000 g for 10 minutes. The pink chromo-
gen was measured at 532 nm in a Beckman DU-7500
spectrophotometer (Beckman Coulter, Brea, CA, USA).
The results were expressed as nmol/mg of protein.Protein assay
Protein levels were measured using the Bradford method
based on the principle of protein-dye binding [36].Chemicals
Unless otherwise stated, the chemicals were from Sigma
Spain, Madrid.Statistical analyses
Data in text and figures are expressed as mean ± SEM.
For multiple comparisons a one-way analysis of variance
followed by the Newman–Keuls post hoc test to compare
all pairs of means between groups was made. When
comparing only two experimental groups a two-tailed t-test
was employed. A P value <0.05 was considered statistically
significant.
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Expression of toll-like receptor-4 signalling pathway
elements in the brain frontal cortex of rats submitted
to stress
The i.p. administration of LPS produced a significant in-
crease in TLR-4 levels in the FC (Figure 1A). This result
suggests that an increase in LPS systemic levels, mimick-
ing an infection, was capable of producing alterations in
TLR-4 expression in this specific brain area.
In order to elucidate whether some elements of the
TLR-4 signalling cascade that activates NF-κB are also
upregulated in rat FC after stress exposure, we then
studied the expression at the mRNA and protein level of
TLR-4, MD-2 and MyD88. In this way, a time course of
TLR-4 expression after 2 hours, 6 hours and 4 daysFigure 1 Time course of toll-like receptor-4 expression after
lipopolysaccharide and restraint stress exposure. Protein levels
of toll-like receptor (TLR)-4 in brain frontal cortex samples of (A) control
and lipopolysaccharide-treated rats (LPS; 500 μg/kg), and (B) stressed
rats during 2 hours (S2h), 6 hours (S6h) and 4 days (2 hours per
day 4 days (6 hours per day)) (S4d). Data are representative of two
experiments (n = 3 to 4 per group in each experiment). Two-tailed
t-test (A) and one-way analysis of variance followed by Newman–Keuls
post hoc test (B). **P< 0.01 versus control. O.D., optical density.(6 hours/day) of restraint stress was made. After 2 hours
of stress exposure, TLR-4 protein expression was not in-
creased but peaked at 6 hours and remained elevated
after 4 days (6 hours/day) of stress (Figure 1B). Comple-
mentary studies using quantitative PCR also showed in-
creased levels of TLR-4 mRNA after 6 hours of stress
exposure (Figure 1B).
Based on these temporal results, we decided to study
the rest of the parameters after 6 hours of restraint
stress exposure.
Cellular types displaying toll-like receptor-4
immunoreactivity in brain frontal cortex
A qualitative approach trying to identify the cellular types
where TLR-4 is expressed in brain FC was made. A de-
tailed examination of the images indicates that TLR-4 is
expressed predominantly in neurons (Figure 2A, B) and at
very low levels in microglia (Figure 2C, D) and astroglia
(Figure 2E, F) both in control and after stress exposure
conditions. TLR-4 immunoreactivity in neurons is uni-
formly distributed in the neuronal soma. In microglia,
the localization of TLR-4 is perinuclear. In the case of
astroglia, TLR-4 immunostaining is slightly present in
astrocyte somata. In addition, no major differences in
TLR-4 expression or cellular distribution were found
between control and stressed rats in the three cellular
types studied.
Possible regulatory mechanisms of toll-like receptor-4
activation in brain frontal cortex after stress
TLR-4 activation by LPS switches on intracellular in-
flammatory pathways. In order to clarify the origin of
the stress-induced activation of the TLR-4 pathway, we
studied the bacterial translocation in MLNs, as well as
LBP mRNA levels in the liver. The group of stressed ani-
mals showed a consistent presence of viable bacterial
CFU per mg of tissue in their MLNs, and an increase in
hepatic LBP mRNA levels compared to the control
group (Figure 3).
The qualitative analysis identified the Gram-
positive bacterial strains Peptostreptococcus, Actino-
myces, Micrococcus, Leuconostoc and Lactobacillus
sp. and the Gram-negative Escherichia coli, Proteus
mirabilis, Enterobacter agglomerans, Porphyromonas
and Bacteroides fragilis in the MLNs of stressed rats
submitted to 6 hours of restraint. All these bacterial
strains are part of the resident intestinal microbiota
of Wistar rats.
Effects of intestinal decontamination on stress-induced
bacterial translocation and toll-like receptor-4 activation
Based on the previous results, we carried out an experi-
ment using antibiotic intestinal decontamination in an at-
tempt to directly demonstrate the role of bacterial
Figure 2 Toll-like receptor-4 immunoreactivity in the brain frontal cortex of rats in control and stress conditions. Sections (30 μm)
through the frontal cortext of rats in (A, C, E) control and (B, D, F) stress conditions. The respective cellular markers appear in green: neurons are
identified with NeuN (A, B), microglia with IBA-1 (C, D) and astroglia with glial fibrillary acidic protein (E, F). In all cases toll-like receptor (TLR)-4 is
marked in red. TLR-4 localizes to the respective cellular marker with some areas of overlap appearing yellow/orange in the merged image (white
arrows in A-F). Scale bars: 20 μm.
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the brain FC after acute restraint stress exposure. We
could not detect any bacterial translocation in the MLNs
of rats treated with antibiotic (Figure 4A). In addition, the
blocking effect of bacterial decontamination is extended
to stress-induced TLR-4, iNOS and COX-2 (Figure 4B-D)
overexpression in brain FC.TAK-242 effects on stress-induced toll-like receptor-4 acti-
vation in brain frontal cortex
TAK-242 i.v. administration at the beginning of the stress
session completely blocked TLR-4 mRNA and protein up-
regulation after stress exposure (Figure 5A, B). On the con-
trary, MD-2 and Myd88 expression remained unaltered
after 6 hours of stress exposure (Figure 5C-F). In addtion,
Figure 3 Bacterial translocation after acute stress exposure.
Effects of TAK-242. (A) Bacteria colony-forming units (CFUs) per mg
of tissue detected in mesenteric lymph nodes of control (CONTROL)
and stressed rats with TAK-242 (S(TAK)) or without TAK-242 (STRESS).
The data represent the CFU/mg found in each animal. (B) Lipopolysac-
charide binding protein (LBP) hepatic mRNA levels of control and
stressed rats with or without TAK-242 (S(TAK) and STRESS, respectively).
mRNA data are normalized by tubulin. Data represent the mean ±
SEM (n = 7 to 8 per group). One-way analysis of variance followed
by Newman–Keuls post hoc test. ***P < 0.05 versus control.
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any conditions (Figure 5C-F).
Effects of TAK-242 on stress-induced bacterial
translocation
In order to clarify whether TAK-242 administration was
able to modify the bacterial translocation elicited by stress
exposure, we compared the bacterial translocation in MLNs
and the LBP hepatic levels in control and stressed animals
with/without i.v. pre-administration of TAK-242. Both
stressed groups of animals (± TAK-242) showed a similar
presence of viable bacterial colony forming units (CFU) per
mg in their MLNs, and increased hepatic LBP mRNA levels
compared to their respective control groups (Figure 3).
Role of toll-like receptor-4 in stress-induced
neuroinflammation and oxidative/nitrosative mediator
over-accumulation in rat brain frontal cortex
To elucidate the possible role of the TLR-4 pathway in the
stress-induced accumulation of inflammatory and oxida-
tive/nitrosative stress mediators, we first determined if thereare alterations in the NF-κB pathway in the FC of control
and stressed animals injected with vehicle or with
TAK-242. After 6 hours of stress, the activity of the
pro-inflammatory subunit of the nuclear factor NF-κB
p65 did not change compared to control conditions
and between both stressed groups of animals (± TAK-
242) (Figure 6A). However, IκBα mRNA levels were in-
creased compared to their control (Figure 6B). Finally,
pharmacological inhibition of TLR4 in stressed animals
was followed by lower levels of IκBα mRNA than stressed
animals without TAK-242 (Figure 6B).
The increase in IκBα mRNA levels could be an auto-
regulatory mechanism switched on by NF-κB to block
its prolonged stimulation, as is the case after 6 hours
of stress exposure. Stress exposure also caused an in-
crease in the protein expression of the NF-κB-dependent
proinflammatory enzymes COX-2 and iNOS in brain FC
(Figure 7A, B). However, under stress conditions, TAK-
242 treated animals did not show an increase in the pro-
tein expression of these enzymes when compared to their
control (Figure 7A, B). Indeed, in the case of COX-2,
pharmacological treatment decreased stress-induced in-
crease in COX-2 protein when compared to stressed ani-
mals without TAK-242 (Figure 7A).
In addition, IL-1β mRNA levels in rat brain FC
were also determined as a specific pro-inflammatory
marker suitable to be affected by the TLR-4 pharma-
cological modulation. Animals receiving TAK-242 did
not show an increase in IL-1β after 6 hours of stress
(Figure 7C). As an additional indicator of stress-
induced cellular damage that could be affected by
TLR-4 selective inhibition, we measured the accumu-
lation of MDA and 4-HNE in the brain FC. Animals
treated with vehicle presented MDA over-accumulation after
stress exposure that was partly prevented by TAK-242 pre-
treatment, although it did not reach statistical significance
(Figure 8A). MDA levels of stressed rats without TAK-242
are not different from the control data (P > 0.05) (Figure 8A).
In the case of 4-HNE, stress produced an over-accumulation
of 4-HNE protein adducts in the brain FC that was fully pre-
vented by the administration of TAK-242 (Figure 8B).
Discussion
The present work shows that acute restraint stress expos-
ure upregulates TLR-4 mRNA and protein expression in
rat brain FC. In addition, the administration of its selective
inhibitor TAK-242 prevents the neuroinflammation and
the accumulation of potentially deleterious oxidative/
nitrosative mediators induced by stress exposure, suggest-
ing a possible regulatory role for TLR-4.
The series of experiments using antibiotic intestinal
decontamination also suggest a role for bacterial trans-
location on TLR-4 signalling pathway activation after
stress exposure. This relationship has also been shown
Figure 4 Intestinal decontamination prevents stress-induced bacterial translocation and toll-like receptor-4 signalling pathway activation.
(A) Bacteria colony-forming units (CFUs) per mg of tissue detected in mesenteric lymph nodes in control (CONTROL) and stressed rats with (S +
ATB) or without (STRESS) antibiotic treatment. The data represent the CFU found in each animal (n = 6 per group). (B) Toll-like receptor (TLR)-4,
(C) inducible nitric oxide synthase (iNOS) and (D) inducible cyclooxygenase (COX-2) protein levels (Western blot) in brain frontal cortex samples
of control and stressed rats with or without antibiotic treatment (S + ATB and STRESS, respectively). For TLR-4, the data are representative of
two experiments (n = 2 to 3 per group in each experiment). One-way analysis of variance followed by Newman–Keuls post hoc test. *P < 0.05
versus control; **P < 0.01 versus control; #P < 0.05 versus stress. O.D., optical density.
Gárate et al. Journal of Neuroinflammation 2014, 11:8 Page 9 of 14
http://www.jneuroinflammation.com/content/11/1/8in sub-chronic and chronic mild stress conditions, using
a similar protocol of antibiotic intestinal decontamin-
ation [24,37].
Previous studies suggest that TLR-4 is a sentinel re-
ceptor that regulates gut barrier permeability. These
studies showed that, in certain experimental pathological
settings (stress exposure included), TLR-4-deficient an-
imals presented an aggravated intestinal dysfunction,
inflammation and subsequent bacterial translocation
[37,38]. Conversely, our results did not show any sig-
nificant effect of TAK-242 on LBP levels and bacterial
translocation after 6 hours of stress exposure. Possible
explanations could be a reduced bioavailability of TAK-
242 at gut level in stress conditions, or the high degree of
bacterial translocation present, making a single dose of
TAK-242 insufficient to affect this process. In this vein,
the great majority of roles proposed for TLR-4 in different
experimental settings have been found using TLR-4
knock-out or TLR-4 functional deficient C3H HeJ mice
[39] instead of its pharmacological modulation, probably
due to the reduced number of potent and specific inhibi-
tors currently available [40].Although we have demonstrated that bacterial trans-
location is responsible, at least in part, for the stress-
induced TLR-4 upregulation, several other non-excluding
mechanisms should not be ruled out, such as the possible
involvement of potential signals conveyed by the vagus
nerve or the sympathetic nervous system. More specific-
ally, TLR-4 could be regulated by other mediators also ac-
tivated by stress, such as heat shock proteins [41] and
other DAMPs [42]. These molecules are also formed in
stress-related disorders in response to LPS activation of
TLR-4 and may re-activate TLR-4, thus closing a vicious
cycle whose consequences should be investigated. In
addition, the excitatory amino acid glutamate that is rap-
idly released after stress exposure in the rat brain FC [43]
is able to regulate TLR-4 via an N-methyl-D-aspartic acid-
dependent mechanism after the systemic administration
of LPS [44]. At the peripheral level, classical stress media-
tors such as epinephrine/norepinephrine/β2 adrenergic re-
ceptor and corticotrophin releasing factor also regulate
TLR-4 expression [45,46].
The number of studies regarding a direct effect of stress
exposure protocols on brain TLR-4 protein expression is
Figure 5 Toll-like receptor-4 upregulation is elicited by acute restraint stress exposure in rat brain frontal cortex. Protein levels of (A)
toll-like receptor (TLR)-4, (C) myeloid differentiation protein-2 (MD2) and (E) myeloid differentiation factor 88 (MyD88) in brain frontal cortex
samples of control (CONTROL) and stressed rats with (S(TAK)) or without (STRESS) TAK-242. The densitometric data of the respective band of
interest are normalized by β-actin (lower band). Data are representative of two experiments (n = 3 per group in each experiment). O.D., optical
density. mRNA relative levels of (B) TLR-4, (D) MD2 and (F) MyD88 in brain frontal cortex samples of control and stressed rats with or without TAK-242
(S(TAK) or STRESS, respectively). mRNA data are normalized by tubulin. Data represent the mean ± SEM (n = 4 to 5 per group). One-way analysis of
variance followed by Newman–Keuls post hoc test. *P < 0.05 versus control; #P < 0.05 versus stress. ##P < 0.01 versus stress. This statistical data
can be used for A and B.
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matory stimulus is systemic LPS and its reported effects are
at the mRNA level, often being contradictory [47,48]. There
are only a few studies checking the effects of restraint stress
on TLR-4, all of them showing increased levels of TLR-4
mRNA in the brain FC, spleen and myocardium of chronic-
ally stressed rats [24,49,50]. In addition, other authors havepreviously shown that TLR4 is upregulated in neurons in
response to a severe inflammatory challenge, such as is-
chaemic stress [51] and that TLR-4 signalling influences
stress-sensitive behaviours in mice, such as spatial reference
memory, fear learning and memory [52].
Our results agree with previous studies also showing
TLR-4 expression in astrocytes [53] and microglia [54]
Figure 6 TAK-242 effects on NF-κB signalling under control and stress conditions. (A) Transcriptional activity of NF-κB p65 subunit in
nuclear extracts of control (CONTROL) and stressed rats with TAK-242 (S(TAK)) or without TAK-242 (STRESS). The data represent the mean ± SEM
(n = 5 per group). One-way analysis of variance followed by Newman–Keuls post hoc test. A.U., arbitrary units. (B) IκBα mRNA relative levels in
brain frontal cortex samples from control and stressed rats with or without TAK-242 (S(TAK) and STRESS, respectively). mRNA data are normalized
by tubulin. Data represent the mean ± SEM (n = 5 to 6 per group). One-way analysis of variance followed by Newman–Keuls post hoc test. versus
control *P < 0.05 ; #P < 0.05 versus stress.
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titative immunohistochemical studies are needed to
identify the nature of the cellular types implicated in the
upregulation of TLR-4 elicited by stress exposure and
the potential function of TLR-4 present in the FC regu-
lating the hypothalamo-pituitary-adrenal axis response
to LPS or other immune/inflammatory challenges.
In addition, the lack of effect of MD-2 and MyD88
under our stress protocol could be indicating that theFigure 7 Anti-inflammatory effects of systemic TAK-242 after stress e
pro-inflammatory enzymes (A) inducible cyclooxygenase (COX-2) and (B) in
respective bands of interest in brain cortex samples from control (CONTRO
The densitometric data of the respective band of interest are normalized b
experiments (n = 3 to 4 per group in each experiment). One-way analysis o
control; #P < 0.05 versus stress. O.D., optical density. (C) IL-1β mRNA relative
or without TAK-242 (S(TAK) and STRESS, respectively). mRNA data are norm
group). One-way analysis of variance followed by Newman–Keuls post hoctime course of activation of both proteins is delayed.
This possibility should be checked in long lasting stress
conditions. In fact, MD-2 is activated after sub-chronic
(2 hours/day during 4 consecutive days) and chronic
mild stress protocols [24,37].
Regarding MyD88, it is possible that other TLR-4
MyD88-independent signal transduction pathways such
as the TRIF-dependent pathway could also be activated
by stress. Finally, a plausible interpretation is that TLR4xposure in rat brain frontal cortex. Western blot detection of the
ducible nitric oxide synthase (iNOS), and densitometric analysis of the
L) and stressed rats with TAK-242 (S(TAK)) or without TAK-242 (STRESS).
y β-actin (lower band). In A and B, the data are representative of two
f variance followed by Newman–Keuls post hoc test. *P < 0.05 versus
levels in brain frontal cortex samples of control and stressed rats with
alized by tubulin. Data represent the mean ± SEM (n = 4 to 5 per
test. *P < 0.05 versus control #P < 0.05 versus stress.
Figure 8 Antioxidant effects of systemic TAK-242 after stress exposure in rat brain frontal cortex. (A) MDA and (B) 4-hydroxynonenal
(4-HNE) protein adduct levels in frontal cortex homogenates of control (CONTROL) and stressed rats with TAK-242 (S(TAK)) or without TAK-242
(STRESS). Data represent the mean ± SEM (n = 5 per group). One-way analysis of variance followed by Newman–Keuls post hoc test. *P < 0.05 versus
control. #P < 0.05 versus stress. O.D., optical density.
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not actually active under these conditions.
To our knowledge, our results showing the effects of
TAK-242 preventing the stress-induced accumulation of
potentially deleterious pro-inflammatory and oxidative/
nitrosative mediators are original. Some authors have re-
ported a similar anti-inflammatory/pro-survival profile
but at a peripheral level in in vivo endotoxic shock
models [55,56] and in in vitro macrophage cultures [25].
Based on all these findings, a potential role as adjunct-
ive therapy in severe sepsis and septic shock has been
suggested for TAK-242 and other drugs targeting the
TLR-4 pathway [57]. However, the result of a clinical
trial evaluating the possible use of TAK-242 for the
treatment of severe sepsis failed, in terms of reducing
the mortality rates in patients [58]. Another clinical trial
checking the efficacy and safety of TAK-242 in patients
with sepsis-induced cardiovascular and respiratory fail-
ure (NCT00633477) is ongoing.
TLRs have also been related to the pathophysiology of di-
verse neurological diseases (multiple sclerosis, Alzheimer’s
disease or stroke [7]), but to our knowledge the great ma-
jority of these studies used genetic approaches and there
are no data assessing the use of TAK-242 for the pharma-
cological inhibition of TLR-4. Clearly, further investigation
is warranted to determine the utility of TAK-242 to regulate
pathological settings with a more moderated innate im-
mune response than the one present in sepsis/endotoxic
shock.
The results presented here suggest that TLR-4 repre-
sents an important regulatory factor in the physiological
response to stress and also support the possibility for
pharmacological manipulations of this pathway in order
to minimize brain oxidative and inflammatory damage
after stress exposure and in stress-related psycho- and
neuropathologies. However, the above comments on thenegative results of the completed clinical trial perfectly
illustrate the necessity for further investigations about
the biology of TLRs to address whether the loss or in-
hibition of TLR-4 is beneficial or predominantly harmful
in pathological scenarios of a different nature. It must be
considered that TLRs constitute a family of receptors
highly conserved between vertebrates with multiple
physiological functions, such as the restoration of CNS
homeostasis after injury [59], the proper resolution of
the inflammatory process [60] or the trigger of fever and
other acute phase responses in response to external
noxia [61].
Indeed, another limitation of our study is that it is not
possible to know if the most relevant role of TLR is at
the CNS level, the periphery, or both. Further studies
with specific TLR-4 knock-out mice for each compart-
ment/cellular type expressing this receptor are needed
to resolve this issue. In addition, complementary studies
regarding TAK-242 ability to cross the brain–blood bar-
rier are needed to determine the proper dose and route
of administration to completely block the central TLR-4
signalling pathway and to optimize the duration of its ef-
fect. In this sense, a recent study has shown that in vivo
TLR4 inhibition, employing the same dose of TAK-242
(0.5 mg/kg) that we have used here, attenuated the
tumour necrosis factor-α, IL-1β and iNOS expression on
microglia post-hypoxia [29].
The elucidation of the mechanisms through which
peripheral PAMP or DAMP can activate central TLR-4
deserves further investigation. One or more of the fol-
lowing unexplored processes may be taking place in our
stress model: 1) circulating leukocytes expressing TLR-4
release inflammatory molecules capable of activating
specific brain areas; 2) direct activation of the TLR-4
present in the brain circumventricular organs and other
leaky structures, such as the choroid plexus and
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by endothelial and perivascular cells forming the blood-
brain barrier; and 4) activation of the TLR-4 expressed
by microglia, astroglia or neurons surrounding brain
microvasculature.
Conclusions
In conclusion, all the data presented here suggest a func-
tional role for TLR-4 in the activation of the immune in-
nate response elicited by acute restraint stress in rats. In
addition, our results suggest that the increased bacterial
translocation produced by stress exposure could be a
reasonable mechanism capable of activating TLR-4.
Finally, the use of TAK-242 and other compounds
interfering with the TLR-4 signalling pathway emerge as
a potential therapeutic adjuvant strategy for the treat-
ment of some neuropsychiatric diseases, such as depres-
sion or chronic fatigue syndrome, characterized by mild
neuroinflammation and oxidative/nitrosative damage.
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